Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (25)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Venn, R. M.
Right arrow Articles by Grounds, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Venn, R. M.
Right arrow Articles by Grounds, R. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2001, Vol. 86, No. 5 650-656
© 2001 The Board of Management and Trustees of the British Journal of Anaesthesia

Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit

R. M. Venn1, A. Bryant2, G. M. Hall2 and R. M. Grounds3

1Department of Anaesthesia and Intensive Care, Worthing Hospital, Lyndhurst Road, Worthing, West Sussex BN11 2DH, UK. 2Department of Anaesthesia and Intensive Care Medicine, St George’s Hospital Medical School, Cranmer Terrace, London SW17 ORE, UK. 3Department of Anaesthesia and Intensive Care Medicine, St George’s Hospital, Blackshaw Road, London SW17 OQT, UK*Corresponding author

We have compared the effects of dexmedetomidine and propofol on endocrine, metabolic, inflammatory and cardiovascular responses in patients in the intensive care unit (ICU) after major surgery. Twenty patients who were expected to require 8 h of post-operative sedation and ventilation were allocated randomly to receive either an infusion of dexmedetomidine 0.2–2.5 µg kg–1 h–1 or propofol 1–3 mg kg–1 h–1. Arterial pressure, heart rate and sequential concentrations of circulating cortisol, adrenocorticotrophic hormone (ACTH), growth hormone, prolactin, insulin, glucose and interleukin 6 were measured. An ACTH stimulation test was performed in all patients who received dexmedetomidine. Heart rate was significantly lower in the dexmedetomidine patients. There were no differences in arterial pressure, cortisol, ACTH, prolactin and glucose concentrations between the two groups. A positive response to the ACTH stimulation test varied depending on the diagnostic criteria used. The insulin concentration was significantly lower in the dexmedetomidine group at 2 h (P=0.021), although this did not affect blood glucose concentrations. Growth hormone concentrations were significantly higher in dexmedetomidine-treated patients overall (P=0.036), but circulating concentrations remained in the physiological range. Interleukin 6 decreased in the dexmedetomidine group. We conclude that dexmedetomidine infusion does not inhibit adrenal steroidogenesis when used for short-term sedation after surgery.

Br J Anaesth 2001: 86: 650–6


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Card Surg AdultHome page
J. H. Levy, K. A. Tanaka, and J. M. Bailey
Cardiac Surgical Pharmacology
Card. Surg. Adult, January 1, 2008; 3(2008): 77 - 110.
[Full Text]

Home page
 The Annals of PharmacotherapyHome page
A. T Gerlach and J. F Dasta
Dexmedetomidine: An Updated Review
Ann. Pharmacother., February 1, 2007; 41(2): 245 - 252.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
P. M. Szumita, S. A. Baroletti, K. E. Anger, and M. E. Wechsler
Sedation and analgesia in the intensive care unit: Evaluating the role of dexmedetomidine
Am. J. Health Syst. Pharm., January 1, 2007; 64(1): 37 - 44.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
V. von Dossow, N. Baehr, M. Moshirzadeh, C. von Heymann, J. P. Braun, O. V. Hein, M. Sander, K.-D Wernecke, W. Konertz, and C. D. Spies
Clonidine Attenuated Early Proinflammatory Response in T-Cell Subsets After Cardiac Surgery
Anesth. Analg., October 1, 2006; 103(4): 809 - 814.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
A. M. Mukhtar, E. M. Obayah, and A. M. Hassona
The use of dexmedetomidine in pediatric cardiac surgery.
Anesth. Analg., July 1, 2006; 103(1): 52 - 56.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
A. M. Mukhtar, E. M. Obayah, and A. M. Hassona
Preliminary experience with dexmedetomidine in pediatric anesthesia.
Anesth. Analg., July 1, 2006; 103(1): 250 - 250.
[Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
G. B. Hammer
The role of alpha2 agonists in pediatric anesthesia
Can J Anesth, June 1, 2005; 52(suppl_1): R9 - R9.
[Full Text] [PDF]

Home page
 Br J AnaesthHome page
G. R. McAnulty and G. M. Hall
Editorial II: Anaesthesia for the diabetic patient
Br. J. Anaesth., April 1, 2003; 90(4): 428 - 429.
[Full Text] [PDF]

Home page
 Br J AnaesthHome page
M. Belhoula, J. P. Ciebiera, A. De La Chapelle, N. Boisseau, D. Coeurveille, and M. Raucoules-Aime
Clonidine premedication improves metabolic control in type 2 diabetic patients during ophthalmic surgery{dagger}
Br. J. Anaesth., April 1, 2003; 90(4): 434 - 439.
[Abstract] [Full Text] [PDF]

Home page
 J Intensive Care MedHome page
E. Martin, G. Ramsay, J. Mantz, and S. T. J. Sum-Ping
The Role of the {alpha}2-Adrenoceptor Agonist Dexmedetomidine in Postsurgical Sedation in the Intensive Care Unit
J Intensive Care Med, January 1, 2003; 18(1): 29 - 41.
[Abstract] [PDF]

Home page
 Card Surg AdultHome page
J. M. Bailey, K. A. Tanaka, and J. H. Levy
Cardiac Surgical Pharmacology
Card. Surg. Adult, January 1, 2003; 2(2003): 85 - 118.
[Full Text]

Home page
 Br J AnaesthHome page
M. P. Shelly
Editorial I: Dexmedetomidine: a real innovation or more of the same?
Br. J. Anaesth., November 1, 2001; 87(5): 677 - 678.
[Full Text] [PDF]

Home page
 Br J AnaesthHome page
R. M. Venn and R. M. Grounds
Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions{dagger}
Br. J. Anaesth., November 1, 2001; 87(5): 684 - 690.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.